After demonstrating the relationship between AQP1 and anthracycline chemotherapy, we intended to apply miRNAs to regulate the expression of AQP1, thereby regulating the sensitivity of breast cancer cells to anthracyclines. The gene discussed is AQP1; the disease is breast carcinoma.